A time trade-off study in the UK, Canada and the US to estimate utilities associated with the treatment of haemophilia
{{output}}
Introduction: Haemophilia is a rare bleeding disorder caused by a deficient or absent clotting factor, leading to frequent bleeding. Multiple intravenous (IV) infusions have been the standard prophylactic treatment; however, newe... ...
